[Utilization of herpes simplex virus-1 thymidine kinase gene in stem cell transplantation therapy].
Tiberghien
P
P
ETS de Franche-Comté, Services d'Hématologie et d'Anatomie-Pathologie, CHU Besançon, France.
Cahn
J Y
JY
Ferrand
C
C
Milpied
N
N
Contassot
E
E
Angonin
R
R
Sallard
D
D
Robinet
E
E
Reynolds
C W
CW
Certoux
J M
JM
Rousseau
E
E
Jacob
W
W
Hervé
W J
WJ
D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006084:Graft Rejection / Q000235:genetics / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation; D018259:Herpesvirus 1, Human / Q000235:genetics*; D006801:Humans; D008212:Lymphocyte Depletion; D013601:T-Lymphocytes / Q000276:immunology; D013937:Thymidine Kinase / Q000235:genetics*
D013937:Thymidine Kinase
Utilisation du gène Thymidine-Kinase du virus Herpès-Simplex-1 comme outil thérapeutique en transplantation de cellules souches hématopoïétiques.